RAREVSSRRK• 7 Days (Normalized)
RARE vs SRRK (Ultragenyx Pharmaceutical Inc. vs Scholar Rock Holding Corporation)
Showing Closing Date Range from Sep, 07 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
RARE Performance $13.61
-8.53%
Ultragenyx Pharmaceutical Inc.
Normalized Baseline0.00%
SRRK Performance $51.85
-9.7%
Scholar Rock Holding Corporation
Normalized Baseline0.00%
Alpha Spread Margin RARE LEADS
+1.17%
RARE outperforming by 1.17%
RARESRRK
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
RARE SRRK
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | RARE Price | RARE Gain (%) | SRRK Price | SRRK Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $13.61 | -8.53% | $51.85 | -9.70% | +1.17% |
| Sep 11, 2026 | $14.30 | -3.90% | $55.41 | -3.50% | -0.40% |
| Sep 10, 2026 | $14.40 | -3.23% | $55.67 | -3.05% | -0.18% |
| Sep 09, 2026 | $14.31 | -3.83% | $54.62 | -4.88% | +1.05% |
| Sep 08, 2026 | $14.88 | +0.00% | $57.42 | +0.00% | +0.00% |